Transcriptomics

Dataset Information

0

The effects of doxorubicin and blocking activin receptor 2B ligands in mice [muscle]


ABSTRACT: Doxorubicin is a widely used and effective anthracycline chemotherapy drug. However, it causes cardiotoxicity and also a few negative effects on skeletal muscle as well. As a result, cancer treatment might actually worsen cancer-induced cachexia and consequently the prognosis of the disease. Inhibiting myostatin/activin signaling is known to increase muscle size. This pathway blockade by soluble activin receptor IIB (sAcvR2B-Fc) has also prolonged survival in cancer, even of animals in which tumor growth is not inhibited. It is not known, however, whether blocking this pathway affects chemotherapy-induced muscle wasting. We found that doxorubicin induces muscle atrophy which is prevented by a blocker for activin receptor 2B ligands (sAcvR2B-Fc).

ORGANISM(S): Mus musculus

PROVIDER: GSE77745 | GEO | 2016/09/25

SECONDARY ACCESSION(S): PRJNA311341

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2017-12-04 | GSE97642 | GEO
2011-02-04 | GSE25306 | GEO
2011-02-04 | E-GEOD-25306 | biostudies-arrayexpress
2017-06-01 | E-MTAB-4943 | biostudies-arrayexpress
2014-10-13 | GSE52766 | GEO
2014-10-13 | E-GEOD-52766 | biostudies-arrayexpress
2017-10-29 | GSE81367 | GEO
2020-09-16 | GSE156321 | GEO
2022-08-15 | GSE210916 | GEO
2016-09-30 | GSE81448 | GEO